FDA Announces Draft Guidance for Human Blood and Blood Components Submission

Summary

The Food and Drug Administration (FDA) has released a draft guidance document to assist applicants in preparing the required sections for a biologics license application (BLA) for human blood and blood components, with the goal of reducing unnecessary burdens for industry while maintaining public health.